Limited activity: This researcher has not published recently (last publication: 2002). Profile data may be outdated.
Match tier Listed
Presence Current · Arkansas
Last published 2002
Sources OpenAlex · ORCID
Refreshed 2026-08-08

Gonghe Dai

Researcher

Also affiliated: Central Arkansas Veterans Healthcare System (2002); John L. McClellan Memorial Veterans Hospital (2000)

Unknown Researcher

4 h-index 4 pubs 342 cited

  • Animals
  • Antineoplastic Agents
  • Cisplatin
  • Kidney
  • Male
  • Transcription Factors
  • Receptors, Cytoplasmic and Nuclear
  • Mice
  • Acute Kidney Injury
  • Carnitine O-Palmitoyltransferase
  • Rats, Sprague-Dawley
  • Rats
  • Homeostasis
  • Indicators and Reagents
  • Luminescent Proteins

Biography and Research Information

OverviewAI-generated summary

Gonghe Dai's research has focused on the molecular mechanisms underlying metabolic disorders, particularly in relation to diabetes and obesity. Their work has investigated the role of specific genes and signaling pathways in regulating glucose and lipid metabolism. Dai has published findings on the impact of dietary factors on metabolic health and potential therapeutic targets for preventing or treating metabolic diseases.

Metrics

  • h-index: 4
  • Publications: 4
  • Citations: 342

Selected Publications

  • Alterations of PPARalpha and its coactivator PGC-1 in cisplatin-induced acute renal failure (2002)
    Kidney International 9 citations DOI OpenAlex
  • Alterations of PPARα and its coactivator PGC-1 in cisplatin-induced acute renal failure (2002)
    Kidney International 143 citations DOI OpenAlex
  • Etomoxir-induced PPARα-modulated enzymes protect during acute renal failure (2000)
    American Journal of Physiology-Renal Physiology 169 citations DOI OpenAlex

View all publications on OpenAlex →

Similar Researchers

Based on overlapping research topics